Two schedules of etirinotecan pegol (NKTR-102) in patients with previously treated metastatic breast cancer: a randomised phase 2 study
Autor: | Awada, Ahmad, Garcia, Agustin A, Chan, Stephen, Jerusalem, Guy H M, Coleman, Robert E, Huizing, Manon T, Mehdi, Aminder, O'Reilly, Sue M, Hamm, John T, Barrett-Lee, Peter J, Cocquyt, Veronique, Sideras, Kostandinos, Young, David E, Zhao, Carol, Chia, Yen Lin, Hoch, Ute, Hannah, Alison L, Perez, Edith A |
---|---|
Zdroj: | In Lancet Oncology November 2013 14(12):1216-1225 |
Databáze: | ScienceDirect |
Externí odkaz: |